GLP-1RAs: Rapid Disruption, Regulatory Shifts & The Rise of Intelligent Health Information In less than a...
TMLabs Blogs
From Patent Cliffs to Next-Gen Blockbusters: Why 2026 Demands Message Resonance at the Heart of Commercial Strategy
The Pharmaceutical Industry in 2026 stands at a critical inflection point - where scientific promise...
Pharma Marketing Crosses Into Consumer Territory
What JPM 2026 Told Us About GLP‑1s, Oncology and the New Rules of Engagement Pharma marketing has finally crossed a...
What Shifting HCP Behavior Means for Client Growth in 2026
Why Understanding HCP Behavior Is Now a Client Risk and Growth Issue As 2026 begins, the environment shaping...
2026 JPM Healthcare Conference Recap and What It Means for Healthcare Strategy
This year’s 44th Annual J.P. Morgan Healthcare Conference (JPM) brought thousands of healthcare leaders, investors and...
Why Message Resonance Is the New ROI Multiplier in Pharma Launches
In the First Two Years, Science Alone Isn’t Enough The pharmaceutical industry has never been more scientifically...
Talking Medicines Recognized in the UK AI Index 2026
We’re pleased to share that Talking Medicines has been included in the Top 1,000 UK AI Companies in the UK AI Index...
From Measurement to Foresight: How Message Resonance Becomes Predictive HCP Intelligence
Why Pharma marketing must move beyond retrospective metrics to understand where HCP narratives are heading next. For...
Top 5 Life Science Trends for 2026
The pace of change across life sciences continues to accelerate, and 2026 will represent a significant step forward in...
AI in Healthcare 2025: We’ve Only Just Begun
Written by: COO/CDO, Founder, Elizabeth Fairley The acceleration is real - but the transformation is going to be...
Bridging the Gap: How AI is Powering Smarter DTC Campaigns with HCP Analytics
More brands are investing in direct-to-consumer (DTC) marketing. But the ones making the biggest impact are using...
The New Competitive Advantage in Pharma Marketing: Measurement That Moves Minds—and Scripts
Written by: COO/CDO, Founder, Elizabeth Fairley In today’s crowded, hyper-competitive pharmaceutical landscape,...





















